CYP2J7 Inhibitors
CYP2J7 inhibitors are a class of chemical compounds specifically designed to target and inhibit the activity of the CYP2J7 enzyme, a member of the cytochrome P450 superfamily. The CYP2J7 enzyme is involved in the oxidative metabolism of a variety of substrates, including endogenous molecules such as fatty acids, eicosanoids, and other bioactive lipids, as well as exogenous substances like certain pharmaceuticals and environmental chemicals. This enzyme plays a crucial role in the hydroxylation of these substrates, a biochemical process that introduces an oxygen atom into the substrate, typically converting lipophilic molecules into more hydrophilic derivatives. This transformation is essential for the subsequent metabolism, conjugation, or excretion of these compounds, aiding in the regulation of lipid signaling pathways and the detoxification processes within the body. CYP2J7's activity is particularly significant in tissues such as the liver, heart, and kidneys, where it contributes to the maintenance of metabolic homeostasis and the processing of bioactive lipids.
Inhibitors of CYP2J7 are typically small molecules that are designed to bind to the enzyme's active site, effectively blocking its ability to catalyze the oxidation of its natural substrates. These inhibitors may function by occupying the enzyme's substrate-binding pocket, preventing the access of substrates to the catalytic core, or by inducing conformational changes that diminish the enzyme's catalytic efficiency. The development of CYP2J7 inhibitors involves detailed structural analysis to identify the critical regions of the enzyme responsible for substrate recognition and catalytic activity. By inhibiting CYP2J7, researchers can gain insights into the enzyme's specific role in lipid metabolism and related pathways, understanding how its inhibition affects the broader network of cytochrome P450-mediated reactions. The study of CYP2J7 inhibitors is crucial for elucidating the enzyme's substrate specificity, its interactions with other metabolic enzymes, and its overall contribution to the regulation of bioactive lipids within the body. This research enhances our understanding of the diverse functions of cytochrome P450 enzymes and their importance in maintaining the balance of metabolic processes within biological systems, particularly in relation to lipid metabolism and detoxification.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Triclosan | 3380-34-5 | sc-220326 sc-220326A | 10 g 100 g | $138.00 $400.00 | ||
Broad-spectrum antibacterial agent known to inhibit CYP2J7. By disrupting the monooxygenase activity, it interferes with the xenobiotic metabolic process, leading to indirect inhibition of the target protein within intracellular membrane-bounded organelles. | ||||||
Fluconazole | 86386-73-4 | sc-205698 sc-205698A | 500 mg 1 g | $53.00 $84.00 | 14 | |
Azole antifungal compound acting as an indirect inhibitor of CYP2J7. It influences the linoleic acid metabolic process, impacting the monooxygenase activity and contributing to the inhibition of the target protein within the cytoplasm. | ||||||
1-Aminobenzotriazole | 1614-12-6 | sc-200600 sc-200600A | 50 mg 100 mg | $60.00 $131.00 | 6 | |
Suicide inhibitor of cytochrome P450 enzymes, including CYP2J7. Through irreversible binding to the heme group, it disrupts the isomerase activity and xenobiotic metabolic process, leading to indirect inhibition of the target protein within intracellular membrane-bounded organelles. | ||||||
Ketoconazole | 65277-42-1 | sc-200496 sc-200496A | 50 mg 500 mg | $62.00 $260.00 | 21 | |
Broad-spectrum antifungal agent with inhibitory effects on CYP2J7. It hinders the isomerase activity, affecting the xenobiotic metabolic process and contributing to indirect inhibition of the target protein within the cytoplasm. | ||||||
Terbinafine | 91161-71-6 | sc-338609 | 100 mg | $560.00 | 1 | |
Antifungal agent in research known to inhibit CYP2J7. By interfering with the monooxygenase activity, it impacts the xenobiotic metabolic process and contributes to indirect inhibition of the target protein within intracellular membrane-bounded organelles. | ||||||
Econazole | 27220-47-9 | sc-279013 | 5 g | $240.00 | ||
Imidazole antifungal agent with inhibitory effects on CYP2J7. It interferes with the monooxygenase activity, impacting the xenobiotic metabolic process and leading to indirect inhibition of the target protein within the cytoplasm. | ||||||
Flutamide | 13311-84-7 | sc-204757 sc-204757A sc-204757D sc-204757B sc-204757C | 1 g 5 g 25 g 500 g 1 kg | $46.00 $153.00 $168.00 $515.00 $923.00 | 4 | |
Antiandrogen drug acting as an indirect inhibitor of CYP2J7. It influences the linoleic acid metabolic process, disrupting the monooxygenase activity and contributing to the inhibition of the target protein within intracellular membrane-bounded organelles. | ||||||
Miconazole | 22916-47-8 | sc-204806 sc-204806A | 1 g 5 g | $65.00 $157.00 | 2 | |
Imidazole antifungal with CYP2J7 inhibitory properties. By interfering with the monooxygenase activity, it impacts the xenobiotic metabolic process, leading to indirect inhibition of the target protein within the cytoplasm. | ||||||
Ticlopidine Hydrochloride | 53885-35-1 | sc-205861 sc-205861A | 1 g 5 g | $31.00 $97.00 | 2 | |
Antiplatelet drug known to inhibit CYP2J7. Through its influence on the isomerase activity, it affects the xenobiotic metabolic process, leading to indirect inhibition of the target protein within intracellular membrane-bounded organelles. | ||||||
Fluoxetine | 54910-89-3 | sc-279166 | 500 mg | $312.00 | 9 | |
Selective serotonin reuptake inhibitor acting as an indirect inhibitor of CYP2J7. It disrupts the isomerase activity, impacting the xenobiotic metabolic process and contributing to the inhibition of the target protein within the cytoplasm. | ||||||